Pharmaceutical

ModeX wins $168m BARDA contract to develop viral antibody therapies

BARDA in the US has awarded a $168m Project NextGen grant to ModeX Therapeutics to develop anti-viral therapies.

Sep 29, 2023 - 20:00
ModeX wins $168m BARDA contract to develop viral antibody therapies
BARDA in the US has awarded a $168m Project NextGen grant to ModeX Therapeutics to develop anti-viral therapies.
Read the original article

Tags:

Previous Article

Karuna Therapeutics files for FDA approval for schizophrenia treatment

Next Article

Can reforms restore faith in India’s pharma industry after cough syrup scandals?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: AI is coming to your dentist’s office. Will it build trust, or erode it?

STAT+: AI is coming to your dentist’s office. Will it b...

Sep 20, 2023

Biostax and Immgenuity to expedite HIV immunotherapies development

Biostax and Immgenuity to expedite HIV immunotherapies ...

Aug 30, 2023

HitGen and SGC enter drug discovery partnership

HitGen and SGC enter drug discovery partnership

Sep 29, 2023